All News Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

End-of-day quote Nasdaq Other stock markets 06:00:00 2024-05-09 pm EDT			5-day change	1st Jan Change
0.8925 ^USD	-2.25%		+6.25%	-96.71%

Apr. 19	Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	MT
Apr. 19	Top Premarket Decliners	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta	Apr. 22	AQ
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product	Apr. 19	MT
Top Premarket Decliners	Apr. 19	MT
Sunshine Biopharma Announces Reverse Stock Split	Apr. 15	AQ
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement	Apr. 12	MT
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	Mar. 28	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Sunshine Biopharma, Inc. announced that it has received $5 million in funding	Mar. 27	CI
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?	Mar. 06	PR
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding	Mar. 03	CI
Sunshine Biopharma, Inc. Announces Executive Changes	Jan. 30	CI
Sunshine Biopharma Moves Principal Office to New York City	Dec. 04	AQ
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City	Dec. 04	CI
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	Nov. 13	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc	Nov. 02	CI
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule	23-09-22	MT
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%	23-08-11	AQ
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.	23-08-10	CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

All News

Filters